Analyst Ratings for Syros Pharmaceuticals (SYRS)

SYRS Rating Summary

  |   Expand Research on SYRS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4.4 / 10   Percentile Rank: 45%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/13/2024 H.C. Wainwright Andrew Fein Downgrade Neutral
(Buy)		 1.00
(6.00)		 2.73
(0.12)		 -95.6% Details
11/13/2024 Brookline Capital Markets Leah Rush Cann Downgrade Hold
(Buy)		 N/A
(N/A)		 2.73
(0.12)		 -95.6% Details